Evidence map›Paper›PMID 36142656›Full record

ArticleInternational journal of molecular sciences2022

Hypoxia and Ezrin Expression in Primary Melanoma Have High Prognostic Relevance.

Umberto Maccio, Alanna Mihic, Daniela Lenggenhager, Isabel Kolm, Christiane Mittmann, Mathias Heikenwälder, Anna Lorentzen, Daniela Mihic-Probst

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Umberto MaccioInstitute of Pathology and Molecular Pathology, University Hospital of Zurich, 8091 Zurich, Switzerland.
Alanna MihicBavarian State Office for Health and Food Safety, 85764 Oberschleißheim, Germany.
Daniela LenggenhagerInstitute of Pathology and Molecular Pathology, University Hospital of Zurich, 8091 Zurich, Switzerland.
Isabel KolmDepartment of Dermatology, University Hospital of Zurich, 8091 Zurich, Switzerland.
Christiane MittmannInstitute of Pathology and Molecular Pathology, University Hospital of Zurich, 8091 Zurich, Switzerland.
Mathias HeikenwälderGerman Cancer Research Center, Division Chronic Inflammation and Cancer, 69120 Heidelberg, Germany.
Anna LorentzenInstitute of Biomedicine, Institute of Molecular Biology and Genetics, Aarhus University, 8000 Aarhus, Denmark.
Daniela Mihic-ProbstInstitute of Pathology and Molecular Pathology, University Hospital of Zurich, 8091 Zurich, Switzerland.ORCID 0000-0002-2215-9958
University Hospital of Zurich · CHAarhus University · DKGerman Cancer Research Center · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypoxia affects tumor aggressiveness and activates pathways associated with epithelial mesenchymal transition (EMT) which are crucial for tumor progress. In this study, the correlation of hypoxia and EMT with sentinel lymph node status and tumor-specific survival was investigated in primary melanomas. CD34 for capillary count and Hypoxia inducible factor-1α (HIF-1α) as hypoxia indicators as well as Ezrin and L1-Cell Adhesion Molecule (L1CAM), both critical proteins contributing to EMT, were analyzed using immunohistochemistry in 49 melanoma patients with long follow-up (F/U, mean 110 months; range 12−263 months). We found a significant correlation between Breslow tumor thickness and Ezrin expression (p = 0.018). L1CAM expression in primary melanoma was significantly associated with HIF-1α expression (p < 0.0001) and sentinel lymph node metastasis (p = 0.011). Furthermore, low capillary count, reflecting hypoxic condition, was significantly associated with Ezrin expression (p = 0.047) and decreased tumor-specific survival (p = 0.035). In addition, patients with high Ezrin expression in their primary melanoma had a dramatic loss of life early in their F/U period (mean survival time 29 months; range 15−44 month). Our results highlight the relevance of Ezrin, L1CAM and HIF-1α as prognostic markers in melanoma patients. Additionally, we demonstrate that hypoxia in primary melanoma affects EMT and is at least partly responsible for early metastatic dissemination.

Indexed as

MelanomaNeural Cell Adhesion Molecule L1Cell HypoxiaCell Line, TumorCytoskeletal ProteinsEpithelial-Mesenchymal TransitionEzrinGene Expression Regulation, NeoplasticHumansHypoxiaHypoxia-Inducible Factor 1, alpha SubunitPrognosisCytoskeletal ProteinsEzrinHypoxia-Inducible Factor 1, alpha SubunitNeural Cell Adhesion Molecule L1cellular transdifferentiationEMTEzrinHIF-1αhypoxiaL1CAMmelanomametastasistumor progressionvascularization

Identifiers

PMID36142656
PMCPMC9502792
OpenAlexW4296280862

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.